China Aoxing Pharmaceutical Company (OTC BB: CAXG), a pharmaceutical company located in China, specializes in researching, developing, manufacturing and distributing a variety of narcotics and pain-management products. The company has China’s largest product pipeline and largest manufacturing facility (1.2 million sq. ft.) for highly regulated narcotic medicines. This facility is one of the few GMP facilities licensed for narcotics medicines.
- 17 years ago
QualityStocks
China Aoxing Pharmaceutical Company (OTC BB: CAXG)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – NextPlat Corp (NASDAQ: NXPL) Narrows Q2 Loss 66% as E-Commerce Growth Offsets Healthcare Headwinds
NextPlat (NASDAQ: NXPL, NXPLW), a global consumer products and services company in healthcare and technology,…
-
QualityStocksNewsBreaks – Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Stands Distinct Against Walker Lane Backdrop
Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF) is positioned as investors view the Walker Lane corridor in…
-
QualityStocksNewsBreaks – Solowin Holdings (NASDAQ: SWIN) Targets $1 Billion AUM for Tokenized USD Money Market Product by Year-End 2025
Solowin (NASDAQ: SWIN), a financial services firm bridging traditional and digital assets, announced an initiative…